AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12969204 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate 30 mg/kg
Number of subjects: 127
Study 12969204 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate 15 mg/kg and 30 mg/kg
Number of subjects: 127
Study 11050638 — intervention group
Group type: EXPERIMENTAL
Intervention: Mangafodipir trisodium (MnDPDP) injection (5 micromol/kg IV)
Number of subjects: 404
Study 8626981 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA) 400 micrograms
Number of subjects: 85
Study 8626981 — intervention group
Group type: COMPARATOR
Intervention: Propellant (placebo)
Number of subjects: 85
Study 1462920 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT imaging with preprocessing masking technique
Number of subjects: 10
Study 1462920 — intervention group
Group type: COMPARATOR
Intervention: SPECT imaging without preprocessing masking technique (before masking)
Number of subjects: 10
Study 1462920 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT imaging with preprocessing masking technique (after masking)
Number of subjects: 10
Study 6734050 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 6734050 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 12
Study 6734050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30947634 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Calls Intervention (MCI)
Number of subjects: 142
Study 30947634 — intervention group
Group type: COMPARATOR
Intervention: Single Call Intervention (SCI)
Number of subjects: 142
Study 30316482 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed Triple P Online
Number of subjects: 183
Study 30316482 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-supported Triple P Online
Number of subjects: 183
Study 30316482 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 183
Study 27049234 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Counseling (AC) intervention
Number of subjects: 182
Study 24106326 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid thoracoscopy
Number of subjects: 90
Study 24106326 — intervention group
Group type: COMPARATOR
Intervention: Semirigid thoracoscopy
Number of subjects: 90
Study 22938019 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the CORAL Decision Aid (DA) in addition to treatment as usual
Number of subjects: 80
Study 22938019 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 80
Study 19706219 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention delivered by local health-care providers
Number of subjects: 599
Study 19706219 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 599
Study 17941770 — intervention group
Group type: EXPERIMENTAL
Intervention: 6F Double‐J stent (group 2)
Number of subjects: 48
Study 17941770 — intervention group
Group type: COMPARATOR
Intervention: 18F Re‐entry nephrostomy tube (group 1)
Number of subjects: 48
Study 15699482 — intervention group
Group type: EXPERIMENTAL
Intervention: OSI‐211 1.8 mg/m(2)/d administered by 30‐minute intravenous infusion on days 1, 2, and 3 every 3 weeks
Number of subjects: 81
Study 15699482 — intervention group
Group type: COMPARATOR
Intervention: OSI‐211 2.4 mg/m(2)/d administered by 30‐minute intravenous infusion on days 1 and 8 every 3 weeks
Number of subjects: 81
Study 15699482 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A (OSI‐211 1.8 mg/m(2)/d)
Number of subjects: 81
Study 15699482 — intervention group
Group type: COMPARATOR
Intervention: Arm B (OSI‐211 2.4 mg/m(2)/d)
Number of subjects: 81
Study 12475836 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose group (7.5 mg albuterol)
Number of subjects: 94
Study 12475836 — intervention group
Group type: COMPARATOR
Intervention: Multidose group (2.5 mg albuterol, three doses)
Number of subjects: 94
Study 12475836 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose group
Number of subjects: 94
Study 12475836 — intervention group
Group type: COMPARATOR
Intervention: Multidose group
Number of subjects: 94
Study 10402692 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-factor model derived from principal components analysis in study 1
Number of subjects: 780
Study 10402692 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised model tested in study 2
Number of subjects: 780
Study 10402692 — intervention group
Group type: COMPARATOR
Intervention: Single-factor model, Kellner's nine-factor model, Ferguson and Daniel's four-factor model, Stewart and Watt's four-factor model
Number of subjects: 780
Study 7486842 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (group A)
Number of subjects: 42
Study 7486842 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 42
Study 2102064 — intervention group
Group type: EXPERIMENTAL
Intervention: PDRN 5 mg ovules
Number of subjects: 91
Study 2102064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 90434 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytodrug (Sabal serrulatum)
Number of subjects: 74
Study 90434 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 74
Study 90434 — intervention group
Group type: COMPARATOR
Intervention: Phytodrug (Sabal serrulatum) with placebo
Number of subjects: 74
Study 29629665 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiphasic cancer screening (including PSA, digital rectal examination, chest x‐ray, flexible sigmoidoscopy, CA125, transvaginal ultrasound)
Number of subjects: 154897
Study 29629665 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiphasic cancer screening
Number of subjects: 154897
Study 26682578 — intervention group
Group type: EXPERIMENTAL
Intervention: Stripping technique
Number of subjects: 51
Study 26682578 — intervention group
Group type: COMPARATOR
Intervention: Combined excisional/ablative technique
Number of subjects: 51
Study 24155264 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct resin composite restorations
Number of subjects: 157
Study 24155264 — intervention group
Group type: COMPARATOR
Intervention: Indirect resin composite restorations
Number of subjects: 157
Study 24430035 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoflavin (2 pills twice per day, total 4 pills daily)
Number of subjects: 100
Study 24430035 — intervention group
Group type: COMPARATOR
Intervention: Standard antidepressant therapy (control)
Number of subjects: 100
Study 20658369 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day bowel preparation with probiotics
Number of subjects: 60
Study 20658369 — intervention group
Group type: COMPARATOR
Intervention: 3-day conventional bowel preparation
Number of subjects: 60
Study 18721256 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglitol administered after meals for 3 months
Number of subjects: 31
Study 18721256 — intervention group
Group type: COMPARATOR
Intervention: Miglitol administered before meals for 3 months
Number of subjects: 31
Study 16845576 — intervention group
Group type: EXPERIMENTAL
Intervention: Denver Model (12 1-h weekly sessions of therapy and daily 1-h home intervention)
Number of subjects: 10
Study 16845576 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMPT (12 1-h weekly sessions of therapy and daily 1-h home intervention)
Number of subjects: 10
Study 16845576 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 10
Study 11433855 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion treatment of questionable incipient carious lesions
Number of subjects: 223
Study 11433855 — intervention group
Group type: COMPARATOR
Intervention: Control group (observed but untreated)
Number of subjects: 223
Study 11433855 — intervention group
Group type: COMPARATOR
Intervention: Air abrasion treatment of carious lesions in control group
Number of subjects: 223
Study 11433855 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive resin-based composite restorations in treatment group
Number of subjects: 223
Study 11433855 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealants in treatment group
Number of subjects: 223
Study 10028299 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 mu kg‐1 rFVIIa
Number of subjects: 116
Study 10028299 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mu kg‐1 rFVIIa
Number of subjects: 116
Study 10028299 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dosages of rFVIIa
Number of subjects: 116
Study 7508071 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (high-dose, up to 7 million KIU)
Number of subjects: 54
Study 7508071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 2735752 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 micrograms of selenium-enriched yeast
Number of subjects: 69
Study 2735752 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 micrograms of selenium-enriched yeast plus 600 IU of vitamin E
Number of subjects: 69
Study 2735752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 1313484 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre (7 g/day)
Number of subjects: 63
Study 1313484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 629867 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA plus topical corticosteroids
Number of subjects: 116
Study 629867 — intervention group
Group type: EXPERIMENTAL
Intervention: Dithranol plus PUVA
Number of subjects: 116
Study 629867 — intervention group
Group type: EXPERIMENTAL
Intervention: Tar plus PUVA
Number of subjects: 116
Study 629867 — intervention group
Group type: COMPARATOR
Intervention: PUVA alone
Number of subjects: 116
Study 31280648 — intervention group
Group type: EXPERIMENTAL
Intervention: Central mean arterial pressure (+11.3 mm Hg)
Number of subjects: 735
Study 31280648 — intervention group
Group type: EXPERIMENTAL
Intervention: Central pulse pressure (+15.2 mm Hg)
Number of subjects: 735
Study 31280648 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentation ratio (+7.0%)
Number of subjects: 735
Study 31280648 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic pulse wave velocity (+1.66 m/s)
Number of subjects: 735
Study 31280648 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward pulse wave (+10.0 mm Hg)
Number of subjects: 735
Study 31280648 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward pulse wave (+8.5 mm Hg)
Number of subjects: 735
Study 31280648 — intervention group
Group type: EXPERIMENTAL
Intervention: Central diastolic blood pressure
Number of subjects: 735
Study 28693535 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfredson isolated eccentric training program (n=43)
Number of subjects: 86
Study 28693535 — intervention group
Group type: COMPARATOR
Intervention: Silbernagel combined concentric-eccentric program (n=43)
Number of subjects: 86
Study 26433183 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole treatment (8 days) with prednisone
Number of subjects: 178
Study 26433183 — intervention group
Group type: COMPARATOR
Intervention: Placebo with prednisone
Number of subjects: 178
Study 23380186 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (2 ng/mL in embryo culture medium)
Number of subjects: 1332
Study 23380186 — intervention group
Group type: COMPARATOR
Intervention: Control (embryo culture medium without GM-CSF)
Number of subjects: 1332
Study 21552714 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment (scaling and root planning, professional prophylaxis, oral hygiene instruction)
Number of subjects: 33
Study 21552714 — intervention group
Group type: COMPARATOR
Intervention: No intervention (received professional prophylaxis and oral hygiene instruction during pregnancy, referred for treatment after delivery)
Number of subjects: 33
Study 21552714 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Number of subjects: 33
Study 21552714 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 33
Study 19407444 — intervention group
Group type: EXPERIMENTAL
Intervention: terutroban (30 mg/day)
Number of subjects: 19119
Study 19407444 — intervention group
Group type: COMPARATOR
Intervention: aspirin (100 mg/day)
Number of subjects: 19119
Study 17265131 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin users with a history of overdose before ATOS
Number of subjects: 387
Study 17265131 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin users with overdose experience in any 1 year
Number of subjects: 387
Study 17265131 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall heroin users
Number of subjects: 387
Study 14673517 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impact exercise intervention for 18 months
Number of subjects: 65
Study 14673517 — intervention group
Group type: COMPARATOR
Intervention: Control group (31 women)
Number of subjects: 65
Study 12361194 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg once daily (o.d.)
Number of subjects: 24
Study 12361194 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg o.d.
Number of subjects: 24
Study 12361194 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg o.d.
Number of subjects: 24
Study 12361194 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 80 mg o.d.
Number of subjects: 24
Study 9719120 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation plus Prednisone (R+P)
Number of subjects: 777
Study 9719120 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation alone (R)
Number of subjects: 777
Study 9719120 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (NT)
Number of subjects: 777
Study 8109547 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid (0.5 to 1.0 g twice daily)
Number of subjects: 158
Study 8109547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg at bedtime)
Number of subjects: 158
Study 8109547 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 158
Study 8109547 — intervention group
Group type: COMPARATOR
Intervention: Nicotinic acid
Number of subjects: 158
Study 8109547 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 158
Study 8109547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 2486560 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cervical adjustments on the side of most restricted end-range
Number of subjects: 0
Study 2486560 — intervention group
Group type: COMPARATOR
Intervention: No intervention or preliminary palpatory and set-up procedures without thrust
Number of subjects: 0
Study 2486560 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cervical adjustments on the less restricted side
Number of subjects: 0
Study 813161 — intervention group
Group type: EXPERIMENTAL
Intervention: Rynacrom (sodium cromoglycate)
Number of subjects: 39
Study 27701082 — intervention group
Group type: EXPERIMENTAL
Intervention: Authoritarian parenting style
Number of subjects: 300
Study 27701082 — intervention group
Group type: EXPERIMENTAL
Intervention: Permissive parenting style
Number of subjects: 300
Study 27701082 — intervention group
Group type: COMPARATOR
Intervention: Authoritative parenting style
Number of subjects: 300
Study 27701082 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal stress in parents of bullies and victims
Number of subjects: 300
Study 28258027 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus DVD (DVD group, n=77)
Number of subjects: 150
Study 28258027 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (control group, n=73)
Number of subjects: 150
Study 25880012 — intervention group
Group type: EXPERIMENTAL
Intervention: CIGB-300 70 mg
Number of subjects: 14
Study 25880012 — intervention group
Group type: EXPERIMENTAL
Intervention: CIGB-300 35 mg
Number of subjects: 14
Study 23591160 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed as second-line treatment after observation
Number of subjects: 464
Study 23591160 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed as second-line treatment after gemcitabine maintenance
Number of subjects: 464
Study 23591160 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed as second-line treatment after erlotinib maintenance
Number of subjects: 464
Study 21114584 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg, intravenous)
Number of subjects: 14
Study 21114584 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 14
Study 19161649 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate group (behavioural intervention promoting lower-GI foods)
Number of subjects: 109
Study 17301091 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of montelukast
Number of subjects: 35
Study 17301091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 14982484 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrotic bowel tissue from patients with radiation enteritis
Number of subjects: 12
Study 14982484 — intervention group
Group type: COMPARATOR
Intervention: Healthy bowel tissue samples from patients without radiation enteritis
Number of subjects: 12
Study 11507800 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral‐B D8
Number of subjects: 113
Study 11507800 — intervention group
Group type: COMPARATOR
Intervention: Colgate Actibrush
Number of subjects: 113
Study 9758289 — intervention group
Group type: EXPERIMENTAL
Intervention: Trovafloxacin 200 mg
Number of subjects: 419
Study 9758289 — intervention group
Group type: EXPERIMENTAL
Intervention: Trovafloxacin 100 mg
Number of subjects: 419
Study 9758289 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid
Number of subjects: 419
Study 7846905 — intervention group
Group type: EXPERIMENTAL
Intervention: En bloc resection (group I)
Number of subjects: 27
Study 7846905 — intervention group
Group type: COMPARATOR
Intervention: Control group (group II)
Number of subjects: 27
Study 2854365 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine-sulphadoxine-pyrimethamine (MSP)
Number of subjects: 0
Study 2854365 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 0
Study 28057378 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (35% fat, 22% MUFA)
Number of subjects: 424
Study 28057378 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (28% fat, 12% MUFA)
Number of subjects: 424
Study 27858526 — intervention group
Group type: EXPERIMENTAL
Intervention: 1st-person narration
Number of subjects: 0
Study 27858526 — intervention group
Group type: COMPARATOR
Intervention: 3rd-person narration
Number of subjects: 0
Study 23710817 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 24
Study 23710817 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study 22624652 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional care with visits from a trained nutritionist 4-8 times at home, tailored nutritional care, protein and nutrient-enriched complementary drinks, vitamin D 20 μg/day for one year
Number of subjects: 202
Study 22624652 — intervention group
Group type: COMPARATOR
Intervention: Written guide on nutrition for older people
Number of subjects: 202
Study 19557391 — intervention group
Group type: EXPERIMENTAL
Intervention: Double bundle (DB) technique
Number of subjects: 40
Study 19557391 — intervention group
Group type: COMPARATOR
Intervention: Single bundle (SB) technique
Number of subjects: 40
Study 19557391 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques (DB and SB)
Number of subjects: 40
Study 19260458 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure with Berci's needle
Number of subjects: 100
Study 19260458 — intervention group
Group type: COMPARATOR
Intervention: Standard hand-sutured technique
Number of subjects: 100
Study 15700052 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg daily) plus calcium (1000 mg daily)
Number of subjects: 19
Study 15700052 — intervention group
Group type: COMPARATOR
Intervention: Calcium (1000 mg daily)
Number of subjects: 19
Study 12953141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive case management
Number of subjects: 0
Study 12953141 — intervention group
Group type: COMPARATOR
Intervention: Standard case management
Number of subjects: 0
Study 10348390 — intervention group
Group type: EXPERIMENTAL
Intervention: Day hospital treatment
Number of subjects: 105
Study 10348390 — intervention group
Group type: COMPARATOR
Intervention: Day centre rehabilitation
Number of subjects: 105
Study 7724182 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (three or more daily insulin injections or continuous subcutaneous insulin infusion, guided by four or more glucose tests daily)
Number of subjects: 1441
Study 7724182 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 1441
Study 1994639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytobrush plus Ayre spatula
Number of subjects: 802
Study 1994639 — intervention group
Group type: COMPARATOR
Intervention: Cervex brush
Number of subjects: 802
Study 6116608 — intervention group
Group type: EXPERIMENTAL
Intervention: Reserpine
Number of subjects: 20
Study 6116608 — intervention group
Group type: COMPARATOR
Intervention: Syrosingopine
Number of subjects: 20
Study 31553890 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest-redistribution (RR; 20 sets of 2 with 15 s inter-set rest)
Number of subjects: 0
Study 31553890 — intervention group
Group type: COMPARATOR
Intervention: Traditional sets (TS; 4 sets of 10 with 95 s inter-set rest)
Number of subjects: 0
Study 31553890 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest-redistribution (RR)
Number of subjects: 0
Study 28122642 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPSV23)
Number of subjects: 900
Study 28122642 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sodium chloride)
Number of subjects: 900
Study 28122642 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 900
Study 28122642 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of interstitial pneumonia
Number of subjects: 900
Study 27207886 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week oral administration of S-1 (80-120 mg/body/day) followed by a 2-week rest (Group A)
Number of subjects: 80
Study 27207886 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week oral administration of S-1 (80-120 mg/body/day) followed by a 1-week rest (Group B)
Number of subjects: 80